메뉴 건너뛰기




Volumn 8, Issue 6, 2011, Pages 691-702

Bioavailability enhancement strategies: Basics, formulation approaches and regulatory considerations

Author keywords

Bioavailability; Lipids; Permeability; Regulatory considerations; Solubility

Indexed keywords

ANION EXCHANGE RESIN; ATORVASTATIN; CALCITONIN; CARBON NANOTUBE; CYCLODEXTRIN; CYCLOSPORIN; CYTOCHROME P450 3A4; DENDRIMER; DIGOXIN; ENZYME; ERYTHROMYCIN; FELODIPINE; HEPARIN; INDOMETACIN; INSULIN; LIPID; LIPOSOME; MIDAZOLAM; NANOMATERIAL; NIOSOME; PENETRATION ENHANCING AGENT; PENICILLIN G; POLYMER; SAQUINAVIR; SOLID LIPID NANOPARTICLE; SURFACTANT; TACROLIMUS; TOPOTECAN;

EID: 80054052328     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720111797635504     Document Type: Review
Times cited : (62)

References (100)
  • 2
    • 34547864243 scopus 로고    scopus 로고
    • Drug delivery strategies for poorly water-soluble drugs
    • Fahr, A.; Liu, X. Drug delivery strategies for poorly water-soluble drugs. Expert Opin. Drug Deliv., 2007, 4 (4), 403-416.
    • (2007) Expert Opin. Drug Deliv , vol.4 , Issue.4 , pp. 403-416
    • Fahr, A.1    Liu, X.2
  • 3
    • 0027686733 scopus 로고
    • Mechanisms, barriers and pathways of oral mucosal drug permeation
    • Rathbone, M.J.; Tucker, I.G. Mechanisms, barriers and pathways of oral mucosal drug permeation. Adv. Drug Deliv. Rev., 1993, 12, 41-60.
    • (1993) Adv. Drug Deliv. Rev , vol.12 , pp. 41-60
    • Rathbone, M.J.1    Tucker, I.G.2
  • 4
    • 0034002854 scopus 로고    scopus 로고
    • Virtual screening of intestinal drug permeability
    • Stenberg, P.; Luthman, K.; Artursson, P. Virtual screening of intestinal drug permeability. J. Control. Release., 2000, 65, 231-243.
    • (2000) J. Control. Release , vol.65 , pp. 231-243
    • Stenberg, P.1    Luthman, K.2    Artursson, P.3
  • 5
    • 0032872193 scopus 로고    scopus 로고
    • Paracellular drug transport across epithelia: Influence of charge and induced water flux
    • Karlsson, J.; Ungell, A.; Grasjo, J.; Artursson, P. Paracellular drug transport across epithelia: influence of charge and induced water flux. Eur. J. Pharm. Sci., 1999, 9, 47-56.
    • (1999) Eur. J. Pharm. Sci , vol.9 , pp. 47-56
    • Karlsson, J.1    Ungell, A.2    Grasjo, J.3    Artursson, P.4
  • 6
    • 0027312774 scopus 로고
    • Selective paracellular permeability in two models of intestinal absorption: Cultured monolayers of human intestinal epithelial cells and rat intestinal segments
    • Artursson, P.; Ungell, A.; Lofroth, J.E. Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharm. Res., 1993, 10, 1123-1129.
    • (1993) Pharm. Res , vol.10 , pp. 1123-1129
    • Artursson, P.1    Ungell, A.2    Lofroth, J.E.3
  • 7
    • 0032403463 scopus 로고    scopus 로고
    • The effect of physical barriers and properties on the oral absorption of particulates
    • Norris, D.A.; Puri, N.; Sinko, P.J. The effect of physical barriers and properties on the oral absorption of particulates. Adv. Drug Deliv. Rev., 1998, 34, 135-154.
    • (1998) Adv. Drug Deliv. Rev , vol.34 , pp. 135-154
    • Norris, D.A.1    Puri, N.2    Sinko, P.J.3
  • 9
    • 17844406157 scopus 로고    scopus 로고
    • Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: A target for drug delivery
    • Cano-Cebrian, M.J.; Zornoza, T.; Granero, L.; Polache, A. Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: A target for drug delivery. Curr. Drug. Deliv., 2005, 2, 9-22.
    • (2005) Curr. Drug. Deliv , vol.2 , pp. 9-22
    • Cano-Cebrian, M.J.1    Zornoza, T.2    Granero, L.3    Polache, A.4
  • 10
    • 0032862501 scopus 로고    scopus 로고
    • Structure and function of tight junctions. Role in intestinal barrier
    • Gasbarrini, G.; Montalto, M. Structure and function of tight junctions. Role in intestinal barrier. Ital. J. Gastroenterol. Hepatol. 1999, 31 (6): 481-488.
    • (1999) Ital. J. Gastroenterol. Hepatol , vol.31 , Issue.6 , pp. 481-488
    • Gasbarrini, G.1    Montalto, M.2
  • 12
    • 0023612699 scopus 로고
    • Structure, biochemistry, and assembly of epithelial tight junctions
    • Gumbiner, B. Structure, biochemistry, and assembly of epithelial tight junctions. Am. J. Physiol., 1987, 253, C749-C758.
    • (1987) Am. J. Physiol , vol.253
    • Gumbiner, B.1
  • 13
    • 0033825953 scopus 로고    scopus 로고
    • Molecular physiology and pathophysiology of tight junctions I. Biogenesis of tight junctions and epithelial polarity
    • Cereijido, L.; Shoshani, L.; Contreras, R.G. Molecular physiology and pathophysiology of tight junctions I. Biogenesis of tight junctions and epithelial polarity. Am J. Physiol. Gastrointest. Liver Physiol., 2000, 279, G477-G482.
    • (2000) Am J. Physiol. Gastrointest. Liver Physiol , vol.279
    • Cereijido, L.1    Shoshani, L.2    Contreras, R.G.3
  • 18
    • 84862752965 scopus 로고    scopus 로고
    • Solvo in vitro transporter assay technology
    • Solvo biotechnology. Available at, Last accessed 4 October
    • Solvo in vitro transporter assay technology. Solvo biotechnology. Available at: www.solvo.com. [Last accessed 4 October 2010].
    • (2010)
  • 19
    • 0035290059 scopus 로고    scopus 로고
    • Active secretion and enterocytic drug metabolism barriers to drug absorption
    • Wacher, V.J.; Salphati, L.; Benet, L.Z. Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug Deliv. Rev., 2001, 46 (1-3), 89-102.
    • (2001) Adv. Drug Deliv. Rev , vol.46 , Issue.1-3 , pp. 89-102
    • Wacher, V.J.1    Salphati, L.2    Benet, L.Z.3
  • 20
    • 0035054725 scopus 로고    scopus 로고
    • The gut as a barrier to drug absorption: Combined role of cytochrome P450 3A and P-glycoprotein
    • Zhang, Y.; Benet, L.Z. The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein. Clin. Pharmacokinet., 2001, 40 (3), 159-168.
    • (2001) Clin. Pharmacokinet , vol.40 , Issue.3 , pp. 159-168
    • Zhang, Y.1    Benet, L.Z.2
  • 21
    • 9444267085 scopus 로고    scopus 로고
    • Functional interaction of intestinal CYP3A4 and P-glycoprotein
    • Kivisto, K.T.; Niemi, M.; Fromm, M.F. Functional interaction of intestinal CYP3A4 and P-glycoprotein. Fundam. Clin. Pharmacol., 2004, 18 (6), 621-626.
    • (2004) Fundam. Clin. Pharmacol , vol.18 , Issue.6 , pp. 621-626
    • Kivisto, K.T.1    Niemi, M.2    Fromm, M.F.3
  • 22
    • 0030581087 scopus 로고    scopus 로고
    • Active secretion and enterocytic drug metabolism barriers to drug absorption
    • Wacher, V.J.; Salphati, L.; Benet, L.Z. Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug Deliv. Rev., 1996, 20, 99-112.
    • (1996) Adv. Drug Deliv. Rev , vol.20 , pp. 99-112
    • Wacher, V.J.1    Salphati, L.2    Benet, L.Z.3
  • 23
    • 0034461768 scopus 로고    scopus 로고
    • Drug-like properties and the causes of poor solubility and poor permeability
    • Lipinski, C.A. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Meth., 2000, 44 (1), 235-249.
    • (2000) J. Pharmacol. Toxicol. Meth , vol.44 , Issue.1 , pp. 235-249
    • Lipinski, C.A.1
  • 24
    • 34447536520 scopus 로고    scopus 로고
    • When poor solubility becomes an issue: From early stage to proof of concept
    • Stegemann, S.; Leveiller, F.; Franchi, D.; de Jong, H. When poor solubility becomes an issue: From early stage to proof of concept. Eur. J. Pharm. Sci., 2007, 31, 249-261.
    • (2007) Eur. J. Pharm. Sci , vol.31 , pp. 249-261
    • Stegemann, S.1    Leveiller, F.2    Franchi, D.3    de Jong, H.4
  • 25
    • 0034713284 scopus 로고    scopus 로고
    • Biopharmaceutics and pharmacokinetics in drug research
    • Panchagnula, R.; and Thomas, N.S. Biopharmaceutics and pharmacokinetics in drug research. Int. J. Pharm., 2000, 201, 131-150.
    • (2000) Int. J. Pharm , vol.201 , pp. 131-150
    • Panchagnula, R.1    Thomas, N.S.2
  • 26
    • 34548049221 scopus 로고    scopus 로고
    • Oral lipid-based formulations
    • Hauss, D.J. Oral lipid-based formulations. Adv. Drug Deliv. Rev., 2007, 59, 667-676.
    • (2007) Adv. Drug Deliv. Rev , vol.59 , pp. 667-676
    • Hauss, D.J.1
  • 27
    • 68349160715 scopus 로고    scopus 로고
    • Lipid-An emerging platform for oral delivery of drugs with poor bioavailability
    • Chakraborty, S.; Shukla, D.; Mishra B, Singh S. Lipid-An emerging platform for oral delivery of drugs with poor bioavailability. Eur. J. Pharm. Biopharm., 2009, 73 (1), 1-15.
    • (2009) Eur. J. Pharm. Biopharm , vol.73 , Issue.1 , pp. 1-15
    • Chakraborty, S.1    Shukla, D.2    Mishra, B.3    Singh, S.4
  • 28
    • 0031914282 scopus 로고    scopus 로고
    • Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly watersoluble LTB4 inhibitor
    • Hauss, D.J.; Fogal, S.E.; Ficorilli, J.V.; Price, C.A.; Roy, T.; Jayaraj, A.A.; Keirns, J.J. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly watersoluble LTB4 inhibitor. J. Pharm. Sci., 1998, 87, 164-169.
    • (1998) J. Pharm. Sci , vol.87 , pp. 164-169
    • Hauss, D.J.1    Fogal, S.E.2    Ficorilli, J.V.3    Price, C.A.4    Roy, T.5    Jayaraj, A.A.6    Keirns, J.J.7
  • 29
    • 0033818432 scopus 로고    scopus 로고
    • Effect of short, medium and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and noncannulated rats
    • Caliph, S.M.; Charman, W.N.; Porter, C.J. Effect of short, medium and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and noncannulated rats. J. Pharm. Sci., 2000, 89, 1073-1084.
    • (2000) J. Pharm. Sci , vol.89 , pp. 1073-1084
    • Caliph, S.M.1    Charman, W.N.2    Porter, C.J.3
  • 30
    • 0029562489 scopus 로고
    • Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects
    • Constantinides, P.P. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res., 1995, 12, 1561-1572.
    • (1995) Pharm. Res , vol.12 , pp. 1561-1572
    • Constantinides, P.P.1
  • 31
    • 55949089032 scopus 로고    scopus 로고
    • A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: Characterization, dissolution, in vitro digestion and incorporation into solid pellets
    • Abdalla, A.; Klein, S.; Mader, K. A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: Characterization, dissolution, in vitro digestion and incorporation into solid pellets. Eur. J. Pharm. Sci., 2008, 35 (5), 457-464.
    • (2008) Eur. J. Pharm. Sci , vol.35 , Issue.5 , pp. 457-464
    • Abdalla, A.1    Klein, S.2    Mader, K.3
  • 32
    • 45849115831 scopus 로고    scopus 로고
    • Development of solid selfemulsifying drug delivery systems: Preparation techniques and dosage forms
    • Tang, B.; Cheng, G.; Gu, J.C.; Xu, C.H. Development of solid selfemulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov. Today, 2008, 13 (13/14), 606-612.
    • (2008) Drug Discov. Today , vol.13 , Issue.13-14 , pp. 606-612
    • Tang, B.1    Cheng, G.2    Gu, J.C.3    Xu, C.H.4
  • 33
    • 78349310868 scopus 로고    scopus 로고
    • Selfemulsifying drug delivery systems: An approach to enhance oral bioavailability
    • Kohli, K.; Chopra, S.; Dhar, D.; Arora, S.; Khar, R.K. Selfemulsifying drug delivery systems: an approach to enhance oral bioavailability. Drug Discov. Today, 2010, 15 (21-22), 958-965.
    • (2010) Drug Discov. Today , vol.15 , Issue.21-22 , pp. 958-965
    • Kohli, K.1    Chopra, S.2    Dhar, D.3    Arora, S.4    Khar, R.K.5
  • 34
    • 10044223246 scopus 로고    scopus 로고
    • Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs
    • Hu, L.D.; Tang, X.; Cui, F. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J. Pharm. Pharmacol., 2004, 56, 1527-1535.
    • (2004) J. Pharm. Pharmacol , vol.56 , pp. 1527-1535
    • Hu, L.D.1    Tang, X.2    Cui, F.3
  • 35
    • 0035667509 scopus 로고    scopus 로고
    • Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent
    • Gupta, M.K.; Goldman, D.; Bogner, R.H.; Tseng, Y.C. Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent. Pharm. Dev. Technol., 2001, 6, 563-572.
    • (2001) Pharm. Dev. Technol , vol.6 , pp. 563-572
    • Gupta, M.K.1    Goldman, D.2    Bogner, R.H.3    Tseng, Y.C.4
  • 36
    • 0038032150 scopus 로고    scopus 로고
    • Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art
    • Muller, R.H.; Mader, K.; Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur. J. Pharm. Biopharm., 2000, 50, 161-177.
    • (2000) Eur. J. Pharm. Biopharm , vol.50 , pp. 161-177
    • Muller, R.H.1    Mader, K.2    Gohla, S.3
  • 38
    • 0035946615 scopus 로고    scopus 로고
    • Solid lipid nanoparticles: Production characterization and applications
    • Mehnert, W.; Mader, K. Solid lipid nanoparticles: production characterization and applications. Adv. Drug Del. Rev., 2001, 47, 165-196.
    • (2001) Adv. Drug Del. Rev , vol.47 , pp. 165-196
    • Mehnert, W.1    Mader, K.2
  • 39
    • 39149113817 scopus 로고    scopus 로고
    • Formulation of lipid-based delivery systems for oral administration: Materials methods and strategies
    • Pouton, C.W.; Porter, C.J.H. Formulation of lipid-based delivery systems for oral administration: materials methods and strategies. Adv. Drug Del. Rev., 2008, 60, 625-637.
    • (2008) Adv. Drug Del. Rev , vol.60 , pp. 625-637
    • Pouton, C.W.1    Porter, C.J.H.2
  • 40
    • 1242292226 scopus 로고    scopus 로고
    • Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations
    • Kaukonen, A.M.; Boyd, B.J.; Porter, C.J.H.; Charman, W.N. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations. Pharm. Res., 2004, 21, 245-253.
    • (2004) Pharm. Res , vol.21 , pp. 245-253
    • Kaukonen, A.M.1    Boyd, B.J.2    Porter, C.J.H.3    Charman, W.N.4
  • 41
    • 67249086096 scopus 로고    scopus 로고
    • Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs
    • Simovic, S.; Heard, P.; Hui, H.; Song, Y.; Peddie, F.; Davey, A.K.; Lewis, A.; Rades, T.; Prestidge, C.A. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs. Mol. Pharm., 2009, 6 (3), 861-872.
    • (2009) Mol. Pharm , vol.6 , Issue.3 , pp. 861-872
    • Simovic, S.1    Heard, P.2    Hui, H.3    Song, Y.4    Peddie, F.5    Davey, A.K.6    Lewis, A.7    Rades, T.8    Prestidge, C.A.9
  • 42
    • 77950591046 scopus 로고    scopus 로고
    • Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems
    • Tan, A.; Simovic, S.; Davey, A.K.; Rades, T.; Boyd, B.J.; Prestidge, C.A. Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems. Mol. Pharm., 2010, 7 (2), 522-532.
    • (2010) Mol. Pharm , vol.7 , Issue.2 , pp. 522-532
    • Tan, A.1    Simovic, S.2    Davey, A.K.3    Rades, T.4    Boyd, B.J.5    Prestidge, C.A.6
  • 43
    • 76249133449 scopus 로고    scopus 로고
    • Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs
    • Wang, F.; Hui, H.; Barnes, T.J.; Barnett, C.; Prestidge, C.A. Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs. Mol. Pharm., 2010, 7 (1), 227-236.
    • (2010) Mol. Pharm , vol.7 , Issue.1 , pp. 227-236
    • Wang, F.1    Hui, H.2    Barnes, T.J.3    Barnett, C.4    Prestidge, C.A.5
  • 44
    • 67349097388 scopus 로고    scopus 로고
    • Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt
    • Chen Y.; Lu, Y.; Chen, J.; Lai, J.; Sun, J.; Hu, F.; Wu, W. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int. J. Pharm., 2009, 376 (1-2), 153-160.
    • (2009) Int. J. Pharm , vol.376 , Issue.1-2 , pp. 153-160
    • Chen, Y.1    Lu, Y.2    Chen, J.3    Lai, J.4    Sun, J.5    Hu, F.6    Wu, W.7
  • 45
    • 58949089131 scopus 로고    scopus 로고
    • Oral cyclosporine A-the current picture of its liposomal and other delivery systems
    • Czogalla, A. Oral cyclosporine A-the current picture of its liposomal and other delivery systems. Cell Mol. Biol. Lett., 2009, 14, 139-152.
    • (2009) Cell Mol. Biol. Lett , vol.14 , pp. 139-152
    • Czogalla, A.1
  • 46
    • 0029070813 scopus 로고
    • Preparation and characterization of liposomes as therapeutic delivery systems: A review
    • Vemuri, S.; Rhodes, C.T. Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharm. Acta Helvetiae., 1995, 70, 95-111.
    • (1995) Pharm. Acta Helvetiae , vol.70 , pp. 95-111
    • Vemuri, S.1    Rhodes, C.T.2
  • 47
    • 69549112751 scopus 로고    scopus 로고
    • Proliposomes of exemestane for improved oral delivery: Formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine
    • Hiremath, P.S.; Soppimath, K.S.; Betageri, G.V. Proliposomes of exemestane for improved oral delivery: Formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine. Int. J. Pharm., 2009, 380 (1-2), 96-104.
    • (2009) Int. J. Pharm , vol.380 , Issue.1-2 , pp. 96-104
    • Hiremath, P.S.1    Soppimath, K.S.2    Betageri, G.V.3
  • 48
    • 0027185555 scopus 로고
    • Study of in vitro and in vivo stability of liposomes loaded with calcitonin or indium in the gastrointestinal tract
    • Arien, A.C.; Goigoux, C.; Dupuy, B.B. Study of in vitro and in vivo stability of liposomes loaded with calcitonin or indium in the gastrointestinal tract. Life Sci., 1993, 53, 1279-1290.
    • (1993) Life Sci , vol.53 , pp. 1279-1290
    • Arien, A.C.1    Goigoux, C.2    Dupuy, B.B.3
  • 49
    • 17644395023 scopus 로고    scopus 로고
    • Oral Delivery of Poorly Soluble Drugs: Part 1
    • Hite, M.; Turner, S.; Federici, C. Oral Delivery of Poorly Soluble Drugs: Part 1. PMPS Summer, 2003, 3, 38-40.
    • (2003) PMPS Summer , vol.3 , pp. 38-40
    • Hite, M.1    Turner, S.2    Federici, C.3
  • 50
    • 79957789430 scopus 로고    scopus 로고
    • Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs
    • Krishnaiah, Y.S.R. Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs. J. Bioequival. Bioavail., 2010, 2 (2), 28-36.
    • (2010) J. Bioequival. Bioavail , vol.2 , Issue.2 , pp. 28-36
    • Krishnaiah, Y.S.R.1
  • 53
    • 34548049483 scopus 로고    scopus 로고
    • Nanosizing-Oral formulation development and biopharmaceutical evaluation
    • Kesisoglou, F.; Panmai, S.; Wu, Y. Nanosizing-Oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev., 2007, 59, 631-644.
    • (2007) Adv. Drug Deliv. Rev , vol.59 , pp. 631-644
    • Kesisoglou, F.1    Panmai, S.2    Wu, Y.3
  • 54
    • 3042814562 scopus 로고    scopus 로고
    • Nanosuspensions: A promising drug delivery strategy
    • Patravale, V.B.; Date, A.A.; Kulkarni, R.M. Nanosuspensions: A promising drug delivery strategy. J. Pharm. Pharmacol., 2004, 56 (7), 827-840.
    • (2004) J. Pharm. Pharmacol , vol.56 , Issue.7 , pp. 827-840
    • Patravale, V.B.1    Date, A.A.2    Kulkarni, R.M.3
  • 55
    • 0035937599 scopus 로고    scopus 로고
    • Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future
    • Muller, R.H.; Jacobs, C.; Kayser, O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev., 2001, 47, 3-19.
    • (2001) Adv. Drug Deliv. Rev , vol.47 , pp. 3-19
    • Muller, R.H.1    Jacobs, C.2    Kayser, O.3
  • 56
    • 38349134916 scopus 로고    scopus 로고
    • Dendrimers as drug carriers: Applications in different routes of drug administration
    • Cheng, Y.; Xu, Z.; Ma, M.; Xu, T. Dendrimers as drug carriers: applications in different routes of drug administration. J. Pharm. Sci., 2008, 97 (1), 123-143
    • (2008) J. Pharm. Sci , vol.97 , Issue.1 , pp. 123-143
    • Cheng, Y.1    Xu, Z.2    Ma, M.3    Xu, T.4
  • 57
    • 0033061971 scopus 로고    scopus 로고
    • Distribution of a lipidic 2.5 nm diameter dendrimer carrier after oral administration
    • Sakthivel, T.; Toth, I.; Florence, A.T. Distribution of a lipidic 2.5 nm diameter dendrimer carrier after oral administration. Int. J. Pharm., 1999, 183 (1), 51-55.
    • (1999) Int. J. Pharm , vol.183 , Issue.1 , pp. 51-55
    • Sakthivel, T.1    Toth, I.2    Florence, A.T.3
  • 58
    • 0034000927 scopus 로고    scopus 로고
    • Oral uptake and translocation of a polylysine dendrimer with a lipid surface
    • Florence A.T.; Sakthivel, T.; Toth, I. Oral uptake and translocation of a polylysine dendrimer with a lipid surface. J. Control. Release, 2000, 65, 253-259.
    • (2000) J. Control. Release , vol.65 , pp. 253-259
    • Florence, A.T.1    Sakthivel, T.2    Toth, I.3
  • 59
    • 0028048082 scopus 로고
    • Bidirectional small-intestinal permeability in the rat to some common marker molecules in-vitro
    • Pantzar, N.; Lundin, S.; Wester, L.; Westrom, B.R. Bidirectional small-intestinal permeability in the rat to some common marker molecules in-vitro. Scand. J. Gastroenterol., 1994, 29, 703-709.
    • (1994) Scand. J. Gastroenterol , vol.29 , pp. 703-709
    • Pantzar, N.1    Lundin, S.2    Wester, L.3    Westrom, B.R.4
  • 60
    • 1542509564 scopus 로고    scopus 로고
    • The use of a dendrimer-Propranolol prodrug to bypass efflux transporters and enhance oral bioavailability
    • D'Emanuele, A.; Jevprasesphant, R.; Penny, J.; Attwood, D. The use of a dendrimer-Propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. J. Control. Release, 2004, 95, 447-453.
    • (2004) J. Control. Release , vol.95 , pp. 447-453
    • D'Emanuele, A.1    Jevprasesphant, R.2    Penny, J.3    Attwood, D.4
  • 63
    • 1542378832 scopus 로고    scopus 로고
    • Overcoming the insolubility of carbon nanotubes through high degrees of sidewall functionalization
    • Dyke, C.A.; Tour, J.M. Overcoming the insolubility of carbon nanotubes through high degrees of sidewall functionalization. Chem. Eur. J., 2004, 10 (4), 812-817.
    • (2004) Chem. Eur. J , vol.10 , Issue.4 , pp. 812-817
    • Dyke, C.A.1    Tour, J.M.2
  • 65
    • 65649083431 scopus 로고    scopus 로고
    • Re-sensitive and highly water-soluble titanate nanotubes
    • Gao, Y.; Zhou, Y.; Yan, D. Re-sensitive and highly water-soluble titanate nanotubes. Polymer, 2009, 50, 2572-2577.
    • (2009) Polymer , vol.50 , pp. 2572-2577
    • Gao, Y.1    Zhou, Y.2    Yan, D.3
  • 66
  • 68
    • 34548134519 scopus 로고    scopus 로고
    • Cyclodextrins as pharmaceutical solubilizers
    • Brewster, M.E.; Loftsson, T. Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev., 2007, 59, 645-666.
    • (2007) Adv. Drug Deliv. Rev , vol.59 , pp. 645-666
    • Brewster, M.E.1    Loftsson, T.2
  • 69
    • 34547864243 scopus 로고    scopus 로고
    • Drug delivery strategies for poorly water-soluble drugs
    • Fahr, A.; Liu, X. Drug delivery strategies for poorly water-soluble drugs. Expert Opin. Drug Deliv., 2007, 4, 403-416.
    • (2007) Expert Opin. Drug Deliv , vol.4 , pp. 403-416
    • Fahr, A.1    Liu, X.2
  • 70
    • 31144433828 scopus 로고    scopus 로고
    • Formulation and biological evaluation of glimepiride-cyclodextrinpolymer systems
    • Ammar, H.O.; Salama, H.A.; Ghorab, M.; Mahmoud, A.A. Formulation and biological evaluation of glimepiride-cyclodextrinpolymer systems. Int. J. Pharm., 2006, 309, 129-138.
    • (2006) Int. J. Pharm , vol.309 , pp. 129-138
    • Ammar, H.O.1    Salama, H.A.2    Ghorab, M.3    Mahmoud, A.A.4
  • 71
    • 35248822616 scopus 로고    scopus 로고
    • The utility of cyclodextrins for enhancing oral bioavailability
    • Carrier, R.L.; Miller L.A.; Ahmed, I. The utility of cyclodextrins for enhancing oral bioavailability. J. Control. Release, 2007, 123, 78-99.
    • (2007) J. Control. Release , vol.123 , pp. 78-99
    • Carrier, R.L.1    Miller, L.A.2    Ahmed, I.3
  • 72
    • 76749145973 scopus 로고    scopus 로고
    • Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with betacyclodextrin and hydroxypropyl-betacyclodextrin
    • Ranpise, N.S.; Kulkarni, N.S.; Mair, P.D.; Ranade, A.N. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with betacyclodextrin and hydroxypropyl-betacyclodextrin. Pharm. Dev. Technol., 2010, 15, 64-70.
    • (2010) Pharm. Dev. Technol , vol.15 , pp. 64-70
    • Ranpise, N.S.1    Kulkarni, N.S.2    Mair, P.D.3    Ranade, A.N.4
  • 73
    • 59049099567 scopus 로고    scopus 로고
    • Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques
    • Al-Marzouqi, A.H.; Elwy, H.M.; Shehadi, I.; Adem, A. Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques. J. Pharm. Biomed. Anal., 2009, 49, 227-233.
    • (2009) J. Pharm. Biomed. Anal , vol.49 , pp. 227-233
    • Al-Marzouqi, A.H.1    Elwy, H.M.2    Shehadi, I.3    Adem, A.4
  • 74
    • 0032885450 scopus 로고    scopus 로고
    • Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs
    • Serajuddin, A.T.M. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci., 1999, 88, 1058-1066.
    • (1999) J. Pharm. Sci , vol.88 , pp. 1058-1066
    • Serajuddin, A.T.M.1
  • 75
    • 26444493103 scopus 로고    scopus 로고
    • Preparation and evaluation of solid dispersion for nitrendipine-carbopol and nitrendipine-HPMCP systems using a twin screw extruder
    • Wang, L.A.; Cui, F.D.; Hayase, T.; Sunada, H. Preparation and evaluation of solid dispersion for nitrendipine-carbopol and nitrendipine-HPMCP systems using a twin screw extruder. Chem. Pharm. Bull., 2005, 53, 1240-1245.
    • (2005) Chem. Pharm. Bull , vol.53 , pp. 1240-1245
    • Wang, L.A.1    Cui, F.D.2    Hayase, T.3    Sunada, H.4
  • 76
    • 29844438761 scopus 로고    scopus 로고
    • Preparation and evaluation of solid dispersions of nitrendipine prepared with fine silica particles using the melt-mixing method
    • Wang, L.; Cui, F.D.; Sunada, H. Preparation and evaluation of solid dispersions of nitrendipine prepared with fine silica particles using the melt-mixing method. Chem. Pharm. Bull., 2006, 54, 37-43.
    • Chem. Pharm. Bull , vol.54 , pp. 37-43
    • Wang, L.1    Cui, F.D.2    Sunada, H.3
  • 77
    • 34548240849 scopus 로고    scopus 로고
    • Solid dispersion of Spironolactone with porous silica prepared by the solvent method
    • Uchino, T.; Yasuno, N.; Yanagihara, Y.; Suzuki, H. Solid dispersion of Spironolactone with porous silica prepared by the solvent method. Pharmazie, 2007, 62, 599-603.
    • (2007) Pharmazie , vol.62 , pp. 599-603
    • Uchino, T.1    Yasuno, N.2    Yanagihara, Y.3    Suzuki, H.4
  • 78
    • 39149138682 scopus 로고    scopus 로고
    • Particle design of poorly water soluble drug substances using supercritical fluid technologies
    • Yasuji, T.; Takeuchi, H.; Kawashima, Y. Particle design of poorly water soluble drug substances using supercritical fluid technologies. Adv. Drug Deliv. Rev., 2008, 60, 388-398.
    • (2008) Adv. Drug Deliv. Rev , vol.60 , pp. 388-398
    • Yasuji, T.1    Takeuchi, H.2    Kawashima, Y.3
  • 79
    • 84862767896 scopus 로고    scopus 로고
    • Solution for poorly water-soluble drugs
    • Fuji chemical industries Co. Ltd, Last accessed October 6, 2010
    • Solution for poorly water-soluble drugs. Fuji chemical industries Co. Ltd., www.fujichemical.co.jp/english (Last accessed October 6, 2010).
  • 80
    • 72049110480 scopus 로고    scopus 로고
    • Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: Chitosan-Oisopropyl-5'-O-d4T monophosphate conjugate
    • Yang, L.; Chen, L.; Zeng, R.; Li, C.; Qiao, R.; Hu, L.; Li, Z. Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: Chitosan-Oisopropyl-5'-O-d4T monophosphate conjugate. Bioorg. Med. Chem., 2010, 18, 117-123.
    • (2010) Bioorg. Med. Chem , vol.18 , pp. 117-123
    • Yang, L.1    Chen, L.2    Zeng, R.3    Li, C.4    Qiao, R.5    Hu, L.6    Li, Z.7
  • 81
    • 84862764854 scopus 로고    scopus 로고
    • Acusphere's Hydrophobic Drug Delivery Systems (HDDS™) Technology Receives Additional Validation, Nanoscience and technology institute. [Last accessed 19 October, 2010]
    • Acusphere's Hydrophobic Drug Delivery Systems (HDDS™) Technology Receives Additional Validation. http://www.nsti.org/press/PRshow.html?id=617. Nanoscience and technology institute. [Last accessed 19 October, 2010].
  • 82
    • 84862765370 scopus 로고    scopus 로고
    • Meeting the challenges of poorly soluble drug compounds
    • Eurand, [Last accessed 15 October, 2010]
    • Meeting the challenges of poorly soluble drug compounds. Eurand www.eurand.com. [Last accessed 15 October, 2010].
  • 83
    • 84862756259 scopus 로고    scopus 로고
    • Solubility and bioavailability enhancers
    • [Last accessed 19 October, 2010]
    • Solubility and bioavailability enhancers. http://www.gattefosse.com/internet/gatt-wk3.nsf/TECHDOCPARCLEF/00000309?OpenDocument&Menu=1. [Last accessed 19 October, 2010].
  • 84
    • 75649095989 scopus 로고    scopus 로고
    • Bioavailability enhancing activities of natural compounds from medicinal plants
    • Kang, M.J.; Cho, J.Y.; Shim, B.H.; Kim, D.K.; Lee, J. Bioavailability enhancing activities of natural compounds from medicinal plants. J. Med. Plants Res., 2009, 3 (13), 1204-1211.
    • (2009) J. Med. Plants Res , vol.3 , Issue.13 , pp. 1204-1211
    • Kang, M.J.1    Cho, J.Y.2    Shim, B.H.3    Kim, D.K.4    Lee, J.5
  • 85
    • 0003455057 scopus 로고    scopus 로고
    • Guidance to industry: Waiver of in vivo BA and BE studies for immediate release solid oral dosage forms based on a biopharmaceutical classification system
    • FDA Guidance
    • FDA Guidance, 2000. Guidance to industry: Waiver of in vivo BA and BE studies for immediate release solid oral dosage forms based on a biopharmaceutical classification system.
    • (2000)
  • 86
    • 1842450785 scopus 로고    scopus 로고
    • A dynamic artificial gastrointestinal system for studying the behaviour of orally administered drug dosage forms under various physiological conditions
    • Blanquet, S.; Zeijdner, E.; Beyssac, E.; Meunier, J.P.; Denis, S.; Havenaar, R.; Alric, M. A dynamic artificial gastrointestinal system for studying the behaviour of orally administered drug dosage forms under various physiological conditions. Pharm. Res., 2004, 21 (4), 585-591.
    • (2004) Pharm. Res , vol.21 , Issue.4 , pp. 585-591
    • Blanquet, S.1    Zeijdner, E.2    Beyssac, E.3    Meunier, J.P.4    Denis, S.5    Havenaar, R.6    Alric, M.7
  • 87
    • 56049112383 scopus 로고    scopus 로고
    • Applications of physiologically based absorption models in drug discovery and development
    • Parrott, N.; Lave, T. Applications of physiologically based absorption models in drug discovery and development. Mol. Pharm., 2008, 5 (5), 760-775.
    • (2008) Mol. Pharm , vol.5 , Issue.5 , pp. 760-775
    • Parrott, N.1    Lave, T.2
  • 88
    • 32344446760 scopus 로고    scopus 로고
    • Role of Caco-2 cell monolayers in prediction of intestinal drug absorption
    • Shah, P.; Jogani, V.; Bagchi, T.; Misra, A. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotechnol. Prog., 2006, 22 (1), 186-198.
    • (2006) Biotechnol. Prog , vol.22 , Issue.1 , pp. 186-198
    • Shah, P.1    Jogani, V.2    Bagchi, T.3    Misra, A.4
  • 90
    • 2642527944 scopus 로고    scopus 로고
    • Combined applications of parallel artificial membrane permeability assay and CaCo-2 permeability assays in drug discovery
    • Kerns, E.H.; Di, L.; Petusky, S.; Farris, M.; Ley, R.; Jupp, P. Combined applications of parallel artificial membrane permeability assay and CaCo-2 permeability assays in drug discovery. J. Pharm. Sci., 2004, 93 (6), 1440-1453.
    • (2004) J. Pharm. Sci , vol.93 , Issue.6 , pp. 1440-1453
    • Kerns, E.H.1    Di, L.2    Petusky, S.3    Farris, M.4    Ley, R.5    Jupp, P.6
  • 92
    • 0027473738 scopus 로고
    • Estimating the fraction dose absorbed from suspensions of poorly soluble substances in humans: A mathematical model
    • Oh D.M.; Curl, R.L.; Amidon, G.L.; Estimating the fraction dose absorbed from suspensions of poorly soluble substances in humans: a mathematical model. Pharm. Res., 1993, 10 (2), 264-270.
    • (1993) Pharm. Res , vol.10 , Issue.2 , pp. 264-270
    • Oh, D.M.1    Curl, R.L.2    Amidon, G.L.3
  • 93
    • 0033427120 scopus 로고    scopus 로고
    • An integrated model for determining causes of poor oral drug absorption
    • Yu, L.X. An integrated model for determining causes of poor oral drug absorption. Pharm. Res., 1999, 16 (12), 1883-1888.
    • (1999) Pharm. Res , vol.16 , Issue.12 , pp. 1883-1888
    • Yu, L.X.1
  • 95
    • 0030444550 scopus 로고    scopus 로고
    • Guidance in the setting of drug particle size specifications to minimize variability in absorption
    • Johnson, K.C.; Swindell, A.C. Guidance in the setting of drug particle size specifications to minimize variability in absorption. Pharm. Res., 1996, 13, 1795-1798.
    • (1996) Pharm. Res , vol.13 , pp. 1795-1798
    • Johnson, K.C.1    Swindell, A.C.2
  • 96
    • 0035478779 scopus 로고    scopus 로고
    • Predicting the impact of physiological and biochemical processes on oral drug bioavailability
    • Agoram, B.; Woltosz, W.S.; Bolger, M.B. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv. Drug Del. Rev., 2001, 50, S41-S61.
    • (2001) Adv. Drug Del. Rev , vol.50
    • Agoram, B.1    Woltosz, W.S.2    Bolger, M.B.3
  • 97
    • 80054078979 scopus 로고    scopus 로고
    • Enhancement & controlled release as synergistic tools
    • Bryan, W.J. Enhancement & controlled release as synergistic tools. Drug Deliv. Technol., 2002, 2 (6).
    • (2002) Drug Deliv. Technol , vol.2 , Issue.6
    • Bryan, W.J.1
  • 99
    • 33748361948 scopus 로고    scopus 로고
    • The use of accelerator mass spectrometry to obtain early human ADME/PK data
    • Lappin, G and Garner, R. The use of accelerator mass spectrometry to obtain early human ADME/PK data. Expert Opin. Drug Metabol. Toxicol. 2005, 1 (1), 23-31.
    • (2005) Expert Opin. Drug Metabol. Toxicol , vol.1 , Issue.1 , pp. 23-31
    • Lappin, G.1    Garner, R.2
  • 100
    • 0026465629 scopus 로고
    • Gamma scintigraphy in the evaluation of pharmaceutical dosage forms
    • Davis, S.S.; Hardy, J.G.; Newman, S.P.; Wilding, I.R. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Eur. J. Nucl. Med., 1992, 19 (11), 971-986.
    • (1992) Eur. J. Nucl. Med , vol.19 , Issue.11 , pp. 971-986
    • Davis, S.S.1    Hardy, J.G.2    Newman, S.P.3    Wilding, I.R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.